Belantamab Mafodotin Shows Real-World Efficacy in Pretreated R/R Myeloma
Cancer Network,
"In our analysis, [belantamab mafodotin] was associated with notable efficacy in patients with heavily pretreated disease who…
Safety and Efficacy of Belantamab Mafadotin in Patients with Relapsed/Refractory Multiple Myeloma: A Real-World Experience
Overview of attention for article published in Blood, November 2024